140 related articles for article (PubMed ID: 17004713)
1. A novel class of potent nonglycosidic and nonpeptidic pan-selectin inhibitors.
Ulbrich HK; Luxenburger A; Prech P; Eriksson EE; Soehnlein O; Rotzius P; Lindbom L; Dannhardt G
J Med Chem; 2006 Oct; 49(20):5988-99. PubMed ID: 17004713
[TBL] [Abstract][Full Text] [Related]
2. Rational design of novel, potent small molecule pan-selectin antagonists.
Kranich R; Busemann AS; Bock D; Schroeter-Maas S; Beyer D; Heinemann B; Meyer M; Schierhorn K; Zahlten R; Wolff G; Aydt EM
J Med Chem; 2007 Mar; 50(6):1101-15. PubMed ID: 17302397
[TBL] [Abstract][Full Text] [Related]
3. Selectin-blocking semisynthetic sulfated polysaccharides as promising anti-inflammatory agents.
Höpfner M; Alban S; Schumacher G; Rothe U; Bendas G
J Pharm Pharmacol; 2003 May; 55(5):697-706. PubMed ID: 12831514
[TBL] [Abstract][Full Text] [Related]
4. The anti-inflammatory effects of a selectin ligand mimetic, TBC-1269, are not a result of competitive inhibition of leukocyte rolling in vivo.
Hicks AE; Abbitt KB; Dodd P; Ridger VC; Hellewell PG; Norman KE
J Leukoc Biol; 2005 Jan; 77(1):59-66. PubMed ID: 15466915
[TBL] [Abstract][Full Text] [Related]
5. No detectable endothelial- or leukocyte-derived L-selectin ligand activity on the endothelium in inflamed cremaster muscle venules.
Eriksson EE
J Leukoc Biol; 2008 Jul; 84(1):93-103. PubMed ID: 18381812
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a potent E-selectin antagonist.
Thoma G; Kinzy W; Bruns C; Patton JT; Magnani JL; Bänteli R
J Med Chem; 1999 Nov; 42(23):4909-13. PubMed ID: 10579852
[TBL] [Abstract][Full Text] [Related]
7. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation.
Schön MP; Krahn T; Schön M; Rodriguez ML; Antonicek H; Schultz JE; Ludwig RJ; Zollner TM; Bischoff E; Bremm KD; Schramm M; Henninger K; Kaufmann R; Gollnick HP; Parker CM; Boehncke WH
Nat Med; 2002 Apr; 8(4):366-72. PubMed ID: 11927942
[TBL] [Abstract][Full Text] [Related]
8. Sialomucin ligands for selectins: a new family of cell adhesion molecules.
Lasky LA
Princess Takamatsu Symp; 1994; 24():81-90. PubMed ID: 8983065
[TBL] [Abstract][Full Text] [Related]
9. Selectins and glycosyltransferases in leukocyte rolling in vivo.
Sperandio M
FEBS J; 2006 Oct; 273(19):4377-89. PubMed ID: 16956372
[TBL] [Abstract][Full Text] [Related]
10. Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: (alpha-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids.
Kogan TP; Dupré B; Keller KM; Scott IL; Bui H; Market RV; Beck PJ; Voytus JA; Revelle BM; Scott D
J Med Chem; 1995 Dec; 38(26):4976-84. PubMed ID: 8544173
[TBL] [Abstract][Full Text] [Related]
11. Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity.
Slee DH; Romano SJ; Yu J; Nguyen TN; John JK; Raheja NK; Axe FU; Jones TK; Ripka WC
J Med Chem; 2001 Jun; 44(13):2094-107. PubMed ID: 11405647
[TBL] [Abstract][Full Text] [Related]
12. Diaryl-dithiolanes and -isothiazoles: COX-1/COX-2 and 5-LOX-inhibitory, *OH scavenging and anti-adhesive activities.
Scholz M; Ulbrich HK; Soehnlein O; Lindbom L; Mattern A; Dannhardt G
Bioorg Med Chem; 2009 Jan; 17(2):558-68. PubMed ID: 19097798
[TBL] [Abstract][Full Text] [Related]
13. Studies on selection blockers. 5. Design, synthesis, and biological profile of sialyl Lewis x mimetics based on modified serine-glutamic acid dipeptides.
Tsukida T; Hiramatsu Y; Tsujishita H; Kiyoi T; Yoshida M; Kurokawa K; Moriyama H; Ohmoto H; Wada Y; Saito T; Kondo H
J Med Chem; 1997 Oct; 40(22):3534-41. PubMed ID: 9357520
[TBL] [Abstract][Full Text] [Related]
14. [Oligosaccharide sulfate inhibitors of selectin-sugar interactions in inflammatory processes].
Auge C; Dagron F; Lemoine R; Le Narvor C; Lubineau A
Ann Pharm Fr; 1999 May; 57(3):216-22. PubMed ID: 10427856
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors.
Kaila N; Thomas BE
Med Res Rev; 2002 Nov; 22(6):566-601. PubMed ID: 12369089
[TBL] [Abstract][Full Text] [Related]
16. Distinct kinetic and mechanical properties govern selectin-leukocyte interactions.
Hanley WD; Wirtz D; Konstantopoulos K
J Cell Sci; 2004 May; 117(Pt 12):2503-11. PubMed ID: 15159451
[TBL] [Abstract][Full Text] [Related]
17. Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.
Wada Y; Saito T; Matsuda N; Ohmoto H; Yoshino K; Ohashi M; Kondo H; Ishida H; Kiso M; Hasegawa A
J Med Chem; 1996 May; 39(10):2055-9. PubMed ID: 8642564
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
Hynes J; Dyckman AJ; Lin S; Wrobleski ST; Wu H; Gillooly KM; Kanner SB; Lonial H; Loo D; McIntyre KW; Pitt S; Shen DR; Shuster DJ; Yang X; Zhang R; Behnia K; Zhang H; Marathe PH; Doweyko AM; Tokarski JS; Sack JS; Pokross M; Kiefer SE; Newitt JA; Barrish JC; Dodd J; Schieven GL; Leftheris K
J Med Chem; 2008 Jan; 51(1):4-16. PubMed ID: 18072718
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists.
Kaila N; Janz K; DeBernardo S; Bedard PW; Camphausen RT; Tam S; Tsao DH; Keith JC; Nickerson-Nutter C; Shilling A; Young-Sciame R; Wang Q
J Med Chem; 2007 Jan; 50(1):21-39. PubMed ID: 17201408
[TBL] [Abstract][Full Text] [Related]
20. BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactions.
Todderud G; Nair X; Lee D; Alford J; Davern L; Stanley P; Bachand C; Lapointe P; Marinier A; Martel A; Menard M; Wright JJ; Bajorath J; Hollenbaugh D; Aruffo A; Tramposch KM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1298-304. PubMed ID: 9316838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
